2008 Barcelona - European Society of Human Genetics

Keyword Index
AMACR gene: P04.182
amazon: P06.163
ambiguous external genitalia: P02.099
Ambivalence: EPL4.2
AME fusion transcript: P04.072
amelogenesis imperfecta: P01.144, P05.005,
P05.110
amenorrhea: P02.183
aminoglycoside antibiotics: C15.5
AML: P04.074, P04.080, P04.081, P04.085,
P04.099, P04.104
amniocentesis: EP14.01, P03.35, P03.48,
P03.60
amniotic fluid: P03.01, P03.30, P03.53,
P08.75, P10.23
amplification of intermethylated sites:
P04.140
amyloid: C03.5
amyloidosis: P07.009
amyotrophic lateral sclerosis: P06.018,
P06.019
Analysis: P06.020
ancestry: EP01.08
Androgen Insensitivity: P02.139
androgen receptor: P04.183
aneuploidy: P02.106, P02.107, P03.13
aneupoloidy abnormalities: P02.226
Angelman Syndrome, Mental Retardation,
Autism: P02.032
Angelman Syndrome: P02.050, P02.051,
P02.054, P02.056, P02.058
Angelman: P02.061
angiogenesis: C02.2
Animal Model: P05.090
aniridia: P06.021
ankyloglossia: P01.135
annotation: P08.27
anodontia: P01.329
anormal chromosomal rearrangement:
P02.094
Antalya: P01.013
antenatal screening: EPL4.1
anticoagulation: P08.82
Antihypertensive: P02.108
antioxidant: P06.077
Antioxidants: P02.230, P10.22
antipsychotic-induced parkinsonism: P06.299
Antisense oligomer induced exon skipping:
P10.11
antisense regulation of transcription: P08.03
Antisense therapeutics: C15.3
Antracyclines: P10.02
anxiety disorder: P02.161
aorta: P01.316
Aortic aneurism: P01.334
aortic aneurysm: P06.323
aortic stenosis: P02.052
aortic valve: P01.243
APC: P04.001, P04.003, P04.004
Apert syndrome: P01.152
aplastic anemia: P02.147
Apo E gene: P06.020
APO E: P06.022
APOA1 gene: P06.017
apoA5*2: P06.173
APOA5: P06.023, P06.024, P06.173
APOB: P05.048
APOE: P01.105, P10.01
Apoptosis genes: C15.6
apoptosis: C02.1, P04.030, P04.176
ARF: P05.050
ARHI: P04.120
ARID: P06.025
ARMR: P05.122
ARMS-PCR: P01.008
array CGH: C04.1, C04.3, C04.5, C04.6,
P02.016, P02.019, P02.022, P02.023,
P02.037, P02.074, P02.082, P02.096,
P02.131, P02.135, P02.173, P02.174,
P02.180, P05.178, P08.25
array painting: P02.197
array-CGH: C01.2, C04.4, C10.2, C13.3,
P01.107, P01.269, P02.017, P02.018,
P02.020, P02.021, P02.024, P02.028,
P02.030, P02.035, P02.086, P02.126,
P02.127, P02.165, P02.211, P04.029,
P04.073, P08.04
arrayCGH: P02.029, P05.148
array-MAPH: P02.035
Arrhythmia: EP10.02
arrhythmogenic right ventricular
cardiomyopathy: C02.4
ARSA: P01.042
art: P02.216
arterial hypertension: P07.010
Arthrogryposis: C03.4, P10.03
Artificial inteligence: P08.05
ARVD/ARVC: P05.091
ARVD5: C02.4
ARX: P01.109
AS: P02.059
ASC: P05.003
ascending or U-shape audiometric curve:
P05.207
ascorbic acid: P10.08
ASF/SF2: C15.6
aspm: P01.318, P06.175
association study: P06.056, P06.061,
P06.079, P06.179, P06.240, P06.249,
P06.257, P06.297
association: P06.011, P06.026, P06.041,
P06.087, P06.104, P06.121, P06.169,
P06.176, P06.264, P06.287, P06.312, PL2.2
associations: P07.070
asthma: P06.027, P06.028, P06.029,
P06.140, P07.011
Asymptomatic neurocutaneous melanosis:
P01.244
AT: P06.180
«at-risk» relatives: EP04.1
AT1R: P07.015
ataxia telangiectasia: P02.109
ataxia: P01.097, P05.059
ATG16L1: P06.069
atherosclerosis: P05.042, P06.030, P06.031
athlete: P06.129, P06.209, P06.233,
P06.238, P06.300
athletes: P06.212, P06.309, P07.003
ATM: P04.121, P05.006
atopic bronchial asthma and lung
tuberculosis: P06.282
atopic eczema: P06.032, P07.012
ATP2A2: P04.122
ATP2A3: P04.122
ATP6V0A4: P05.014
ATP6V1B1: P05.014
ATP7A/B: P05.139
ATP7B gene: P07.131
ATP7B: P01.049, P01.073
ATP-ase subunit 8: P01.245
ATPase: P05.128
Atrophy: P07.119
ATRX gene: P01.246
ATRX: P01.085
ATR-X: P01.246
ATTCT repeat: P05.174
Attention: P06.235
attitudes: EP09.1
ATXN3: P05.187
atypical CML: P04.082
Atypical: P02.214
auditory neuropathy: P07.013
autism spectrum disorders: P01.319,
P07.014
autism: P01.080, P01.089, P01.247,
P01.248, P02.067, P02.068, P02.092,
P02.095, P02.110, P05.007, P06.033,
P06.034, P06.035, P06.271
autistic features: P02.161
auto-brewery syndrome: P05.008
autoimmune diseases: C08.1, P06.036
Autoimmune regulator (AIRE): P05.009
autoimmune thyroid disease: P06.072
autoimmune: C08.5
autoimmunity: P06.086
automated nucleic acid purification: P08.44
autonomy: P09.65, P09.66
autophosphorylation: S13.3
autosomal aneuplodies: P03.10
Autosomal dominant Alport Syndrome:
P01.249
Autosomal Dominant Polycystic Kidney
Disease: P05.217, P06.234
Autosomal dominant: C06.5, P01.297,
P06.037, P06.064
autosomal recessive mental retardation:
P06.025
autosomal recessive: EP10.08, P01.161,
P06.160
autozygosity mapping: P01.096
Axenfeld-Rieger: P01.250
axillary osmidrosis: P06.038
Aymaras: P07.139
AZF deletions: P02.242
AZF: P02.240
AZFc locus: P02.233
AZFC region: P09.63
azoospermia: P02.221, P02.222, P02.240
Azores: P06.044, P06.050, P07.127
β2-adrenergic receptor (ADRB2)
polymorphisms: P06.318